224 related articles for article (PubMed ID: 22042099)
1. Content of vascular endothelial growth factor in stratum corneum well correlates to local severity of acute inflammation in patients with atopic dermatitis.
Amarbayasgalan T; Takahashi H; Dekio I; Morita E
Int Arch Allergy Immunol; 2012; 157(3):251-8. PubMed ID: 22042099
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis.
Amarbayasgalan T; Takahashi H; Dekio I; Morita E
Int Arch Allergy Immunol; 2013; 160(1):63-74. PubMed ID: 22948248
[TBL] [Abstract][Full Text] [Related]
3. Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis.
Zhang Y; Matsuo H; Morita E
Arch Dermatol Res; 2006 Mar; 297(9):425-9. PubMed ID: 16456664
[TBL] [Abstract][Full Text] [Related]
4. Instrumental assessment of atopic eczema: validation of transepidermal water loss, stratum corneum hydration, erythema, scaling, and edema.
Holm EA; Wulf HC; Thomassen L; Jemec GB
J Am Acad Dermatol; 2006 Nov; 55(5):772-80. PubMed ID: 17052481
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor (MIF) in the stratum corneum: a marker of the local severity of atopic dermatitis.
Yasuda C; Enomoto A; Ishiwatari S; Mori N; Kagoyama K; Matsunaga K; Yoshihisa Y; Matsukuma S; Shimizu T
Exp Dermatol; 2014 Oct; 23(10):764-6. PubMed ID: 25056219
[TBL] [Abstract][Full Text] [Related]
7. Increased stratum corneum serine protease activity in acute eczematous atopic skin.
Voegeli R; Rawlings AV; Breternitz M; Doppler S; Schreier T; Fluhr JW
Br J Dermatol; 2009 Jul; 161(1):70-7. PubMed ID: 19416247
[TBL] [Abstract][Full Text] [Related]
8. Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis.
Furue M; Matsumoto T; Yamamoto T; Takeuchi S; Esaki H; Chiba T; Yamaguchi H
J Dermatol Sci; 2012 Apr; 66(1):60-3. PubMed ID: 22391243
[TBL] [Abstract][Full Text] [Related]
9. Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis.
Morita E; Takahashi H; Niihara H; Dekio I; Sumikawa Y; Murakami Y; Matsunaka H
Allergy; 2010 Sep; 65(9):1166-72. PubMed ID: 20374230
[TBL] [Abstract][Full Text] [Related]
10. Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatitis.
Hachisuka J; Takeuchi S; Kido M; Fukiwake N; Furue M
Int J Dermatol; 2009 Apr; 48(4):374-8. PubMed ID: 19335422
[TBL] [Abstract][Full Text] [Related]
11. Assessment of atopic eczema: clinical scoring and noninvasive measurements.
Holm EA; Wulf HC; Thomassen L; Jemec GB
Br J Dermatol; 2007 Oct; 157(4):674-80. PubMed ID: 17672874
[TBL] [Abstract][Full Text] [Related]
12. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease.
Sugarman JL; Fluhr JW; Fowler AJ; Bruckner T; Diepgen TL; Williams ML
Arch Dermatol; 2003 Nov; 139(11):1417-22. PubMed ID: 14623701
[TBL] [Abstract][Full Text] [Related]
13. Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis.
Kim DW; Park JY; Na GY; Lee SJ; Lee WJ
Int J Dermatol; 2006 Jun; 45(6):698-701. PubMed ID: 16796631
[TBL] [Abstract][Full Text] [Related]
14. Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis.
Lee CH; Chuang HY; Shih CC; Jong SB; Chang CH; Yu HS
Br J Dermatol; 2006 Jun; 154(6):1100-7. PubMed ID: 16704640
[TBL] [Abstract][Full Text] [Related]
15. Human β-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis.
Clausen ML; Jungersted JM; Andersen PS; Slotved HC; Krogfelt KA; Agner T
Br J Dermatol; 2013 Sep; 169(3):587-93. PubMed ID: 23647067
[TBL] [Abstract][Full Text] [Related]
16. Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products.
Tagami H; Kobayashi H; O'goshi K; Kikuchi K
J Cosmet Dermatol; 2006 Jun; 5(2):140-9. PubMed ID: 17173589
[TBL] [Abstract][Full Text] [Related]
17. Linoleic acid metabolite levels and transepidermal water loss in children with atopic dermatitis.
Yen CH; Dai YS; Yang YH; Wang LC; Lee JH; Chiang BL
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):66-73. PubMed ID: 18254485
[TBL] [Abstract][Full Text] [Related]
18. Pyrrolidone carboxylic acid levels or caspase-14 expression in the corneocytes of lesional skin correlates with clinical severity, skin barrier function and lesional inflammation in atopic dermatitis.
Jung M; Choi J; Lee SA; Kim H; Hwang J; Choi EH
J Dermatol Sci; 2014 Dec; 76(3):231-9. PubMed ID: 25315296
[TBL] [Abstract][Full Text] [Related]
19. Microanalysis of an antimicrobial peptide, beta-defensin-2, in the stratum corneum from patients with atopic dermatitis.
Asano S; Ichikawa Y; Kumagai T; Kawashima M; Imokawa G
Br J Dermatol; 2008 Jul; 159(1):97-104. PubMed ID: 18476959
[TBL] [Abstract][Full Text] [Related]
20. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis.
Hon KL; Lam MC; Leung TF; Kam WY; Lee KC; Li MC; Fok TF; Ng PC
Br J Dermatol; 2006 Apr; 154(4):629-35. PubMed ID: 16536804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
